Brimonidine Tartrate 60505-0564
Product NDC
60505-0564- Manufacturer
- Apotex Corp.
- Dosage Form
- Solution/ Drops
- Route
- Ophthalmic
- Product Type
- Human Prescription Drug
- Marketing Start
- January 31, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA078479
Need to source Brimonidine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Brimonidine Tartrate | 1.5 mg/mL |
Drug Class
Adrenergic alpha-Agonists [MoA]alpha-Adrenergic Agonist [EPC]
Packaging Options(3)
1 BOTTLE, DROPPER in 1 CARTON (60505-0564-1) / 5 mL in 1 BOTTLE, DROPPER
1 BOTTLE, DROPPER in 1 CARTON (60505-0564-2) / 10 mL in 1 BOTTLE, DROPPER
1 BOTTLE, DROPPER in 1 CARTON (60505-0564-3) / 15 mL in 1 BOTTLE, DROPPER